Fenofibrate prevents skeletal muscle loss in mice with lung cancer [Medical Sciences]
The cancer anorexia cachexia syndrome is a systemic metabolic disorder characterized by the catabolism of stored nutrients in skeletal muscle and adipose tissue that is particularly prevalent in nonsmall cell lung cancer (NSCLC). Loss of skeletal muscle results in functional impairments and increased mortality. The aim of the present study...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Marcus D. Goncalves, Seo-Kyoung Hwang, Chantal Pauli, Charles J. Murphy, Zhe Cheng, Benjamin D. Hopkins, David Wu, Ryan M. Loughran, Brooke M. Emerling, Guoan Zhang, Douglas T. Fearon, Lewis C. Cantley Tags: PNAS Plus Source Type: research
More News: Academies | Anorexia | Cancer | Cancer & Oncology | Eating Disorders & Weight Management | Fenofibrate | Lung Cancer | Non-Small Cell Lung Cancer | Nutrition | Study | Tricor